RT @AnnSurgOncol: SEPTEMBER ISSUE: A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage II…
RT @AnnSurgOncol: SEPTEMBER ISSUE: A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage II…
RT @AnnSurgOncol: SEPTEMBER ISSUE: A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage II…
RT @AnnSurgOncol: SEPTEMBER ISSUE: A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage II…
RT SocSurgOnc RT AnnSurgOncol: SEPTEMBER ISSUE: A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III #CutaneousMalignantMelanoma in Sweden. https://t.co/rL8WrzBVKu McMastersKelly SocSurgOnc https://t.co/
RT @AnnSurgOncol: SEPTEMBER ISSUE: A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage II…
SEPTEMBER ISSUE: A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III #CutaneousMalignantMelanoma in Sweden. https://t.co/5xYfxdeBbn @McMastersKelly @SocSurgOnc https://t.co/sGVAXqXmWa
RT @OlofssonBagge: Just published our article comparing AJCC 7 vs AJCC 8 for stage III melanoma, important when considering adjuvant treatm…
Just published our article comparing AJCC 7 vs AJCC 8 for stage III melanoma, important when considering adjuvant treatment!!! https://t.co/ctTOCS6mrh
A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden. https://t.co/duELuC9Sac